Michèle Cavo
Active 1991–2025
- Also published as
- Michele Cavo
- 321
- Papers
- 61,112
- Citations
- 120
- h-index
- 307
- i10-index
Citations
Citation sources
Countries
Institutions
Fields
- Medicine80.7%
- Biochemistry, Genetics and Molecular Biology13.8%
- Immunology and Microbiology2.6%
- Computer Science0.5%
- Engineering0.4%
- Nursing0.4%
- Other1.6%
Topics
- Multiple Myeloma Research and Treatments17%
- Protein Degradation and Inhibitors6.7%
- CAR-T cell therapy research5.8%
- Peptidase Inhibition and Analysis3.9%
- Amyloidosis: Diagnosis, Treatment, Outcomes2.8%
- Cancer Treatment and Pharmacology2.6%
- Other61.2%
Coauthors
- Meletios Α. Dimopoulos92
- Elena Zamagni76
- Philippe Moreau76
- Jesús F. San Miguel67
- María‐Victoria Mateos61
- Pieter Sonneveld57
- Mario Boccadoro56
- Antonio Palumbo53
- Roman Hájek48
- Francesca Gay45
- Meral Beksaç44
- Hartmut Goldschmidt43
- Hermann Einsele39
- Heinz Ludwig38
- Pellegrino Musto34
- Evangelos Terpos33
- Paul G. Richardson33
- Joan Bladé31
- Maria Teresa Petrucci31
- Michel Delforge31
- Xavier Leleu31
- Paola Tacchetti30
- Thierry Façon30
- Shaji Kumar29
All papers
- Idecabtagene Vicleucel in Relapsed and Refractory Multiple Myeloma
Authors: Nikhil C. Munshi, Larry D. Anderson, Nina Shah, Deepu Madduri, Jesús G. Berdeja, Sagar Lonial, Noopur Raje, Yi Lin, David S. Siegel, Albert Oriol, Philippe Moreau, Ibrahim Yakoub‐Agha, Michel Delforge, Michèle Cavo, Hermann Einsele, Hartmut Goldschmidt, Katja Weisel, Alessandro Rambaldi, Donna Reece, Fabio Petrocca, Monica Massaro, Jamie N. Connarn, Shari M. Kaiser, Payal Patel, Liping Huang, Timothy Campbell, Kristen Hege, Jesús F. San Miguel - New England Journal of Medicine 2021 cited by 2,424
- International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma
Authors: Shaji Kumar, Bruno Paiva, Kenneth C. Anderson, Brian G.M. Durie, Ola Landgren, Philippe Moreau, Nikhil C. Munshi, Sagar Lonial, Joan Bladé, María‐Victoria Mateos, Meletios Α. Dimopoulos, Efstathios Kastritis, Mario Boccadoro, Robert Z. Orlowski, Hartmut Goldschmidt, Andrew Spencer, Jian Hou, Wee Joo Chng, Saad Z. Usmani, Elena Zamagni, Kazuyuki Shimizu, Sundar Jagannath, Hans Erik Johnsen, Evangelos Terpos, Tony Reiman, Robert A. Kyle, Pieter Sonneveld, Paul G. Richardson, Philip L. McCarthy, Heinz Ludwig, Wen-Ming Chen, Michèle Cavo, Jean‐Luc Harousseau, Suzanne Lentzsch, Jens Hillengaß, Antonio Palumbo, Alberto Órfão, S. Vincent Rajkumar, Jesús F. San Miguel, Hervé Avet‐Loiseau - The Lancet Oncology 2016 cited by 2,995
- International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma
Authors: S. Vincent Rajkumar, Meletios Α. Dimopoulos, Antonio Palumbo, Joan Bladé, Giampaolo Merlini, María‐Victoria Mateos, Shaji Kumar, Jens Hillengaß, Efstathios Kastritis, Paul G. Richardson, Ola Landgren, Bruno Paiva, Angela Dispenzieri, Brendan M. Weiss, Xavier Leleu, Sonja Zweegman, Sagar Lonial, Laura Rosiñol, Elena Zamagni, Sundar Jagannath, Orhan Sezer, Sigurður Y. Kristinsson, Jo Caers, Saad Z. Usmani, Juan José Lahuerta, Hans Erik Johnsen, Meral Beksaç, Michèle Cavo, Hartmut Goldschmidt, Evangelos Terpos, Robert A. Kyle, Kenneth C. Anderson, Brian G.M. Durie, Jesús F. San Miguel - The Lancet Oncology 2014 cited by 4,869
- Cilta-cel or Standard Care in Lenalidomide-Refractory Multiple Myeloma
Authors: Jesús F. San Miguel, Binod Dhakal, Kwee Yong, Andrew Spencer, Sébastien Anguille, María‐Victoria Mateos, Carlos Fernández de Larrea, Joaquín Martínez‐López, Philippe Moreau, Cyrille Touzeau, Xavier Leleu, Irit Avivi, Michèle Cavo, Tadao Ishida, Seok Jin Kim, Wilfried Roeloffzen, Niels W.C.J. van de Donk, Dominik Dytfeld, Surbhi Sidana, Luciano J. Costa, Albert Oriol, Rakesh Popat, Abdullah Khan, Yaël C. Cohen, P. Joy Ho, James E. Griffin, Nikoletta Lendvai, Carolina Lonardi, Ana Slaughter, Jordan M. Schecter, Carolyn C. Jackson, Kaitlyn Connors, Katherine Li, Enrique Zudaire, Diana Chen, Jane Gilbert, Tzu‐Min Yeh, Sarah Nagle, Erika Florendo, Lida Pacaud, Nitin Patel, Simon J. Harrison, Hermann Einsele - New England Journal of Medicine 2023 cited by 733
- Ide-cel or Standard Regimens in Relapsed and Refractory Multiple Myeloma
Authors: Paula Rodríguez‐Otero, Sikander Ailawadhi, Bertrand Arnulf, Krina K. Patel, Michèle Cavo, Ajay K. Nooka, Salomon Manier, Natalie S. Callander, Luciano J. Costa, Ravi Vij, Nizar J. Bahlis, Philippe Moreau, Scott R. Solomon, Michel Delforge, Jesús G. Berdeja, Anna Truppel-Hartmann, Zhihong Yang, Linda Favre‐Kontula, Fan Wu, Julia Piasecki, Mark Cook, Sergio Giralt - New England Journal of Medicine 2023 cited by 705
- Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group
Authors: Antonio Palumbo, Hervé Avet‐Loiseau, Stefania Oliva, Henk M. Lokhorst, Hartmut Goldschmidt, Laura Rosiñol, Paul Richardson, S Caltagirone, Juan José Lahuerta, Thierry Façon, Sara Bringhen, Francesca Gay, Michel Attal, Roberto Passera, Andrew Spencer, Massimo Offidani, Shaji Kumar, Pellegrino Musto, Sagar Lonial, Maria Teresa Petrucci, Robert Z. Orlowski, Elena Zamagni, Gareth J. Morgan, Meletios Α. Dimopoulos, Brian G.M. Durie, Kenneth C. Anderson, Pieter Sonneveld, Jesús F. San Miguel, Michèle Cavo, S. Vincent Rajkumar, Philippe Moreau - Journal of Clinical Oncology 2015 cited by 2,178
- Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma
Authors: Pieter Sonneveld, Meletios Α. Dimopoulos, Mario Boccadoro, Hang Quach, P. Joy Ho, Meral Beksaç, Cyrille Hulin, Elisabetta Antonioli, Xavier Leleu, Silvia Mangiacavalli, Aurore Perrot, Michèle Cavo, Angelo Belotti, Annemiek Broijl, Francesca Gay, Roberto Mina, Inger S. Nijhof, Niels W.C.J. van de Donk, Eirini Katodritou, Fredrik Schjesvold, Anna Sureda, Laura Rosiñol, Michel Delforge, Wilfried Roeloffzen, Tobias Silzle, Annette Juul Vangsted, Hermann Einsele, Andrew Spencer, Roman Hájek, Artur Jurczyszyn, Sarah Lonergan, Tahamtan Ahmadi, Yanfang Liu, Jianping Wang, Diego Vieyra, Emilie M.J. van Brummelen, Véronique Vanquickelberghe, Anna Sitthi-Amorn, Carla J. de Boer, Robin Carson, Paula Rodríguez‐Otero, Joan Bladé, Philippe Moreau - New England Journal of Medicine 2023 cited by 515
- Multiple Myeloma: EHA-ESMO Clinical Practice Guidelines for Diagnosis, Treatment and Follow-up.
Authors: Meletios Α. Dimopoulos, Philippe Moreau, Evangelos Terpos, María‐Victoria Mateos, Sonja Zweegman, Gordon Cook, Michel Delforge, Roman Hájek, Fredrik Schjesvold, Michèle Cavo, Hartmut Goldschmidt, Thierry Façon, Hermann Einsele, Mario Boccadoro, Jesús F. San Miguel, Pieter Sonneveld, Ulrich Mey - Annals of Oncology 2021 cited by 820
- Second Revision of the International Staging System (R2-ISS) for Overall Survival in Multiple Myeloma: A European Myeloma Network (EMN) Report Within the HARMONY Project
Authors: Mattia D’Agostino, David A. Cairns, Juan José Lahuerta, Ruth Wester, Uta Bertsch, Anders Waage, Elena Zamagni, María‐Victoria Mateos, Daniele Dall’Olio, Niels W.C.J. van de Donk, Graham Jackson, Serena Rocchi, Hans Salwender, Joan Bladé Creixenti, Bronno van der Holt, Gastone Castellani, Francesca Bonello, Andréa Capra, K. Elias, Jan Dürig, Francesca Gay, Sonja Zweegman, Michèle Cavo, Martin Kaiser, Hartmut Goldschmidt, Jesús María Hernández‐Rivas, Alessandra Larocca, Gordon Cook, Jesús F. San Miguel, Mario Boccadoro, Pieter Sonneveld - Journal of Clinical Oncology 2022 cited by 407
- Prevention and management of adverse events during treatment with bispecific antibodies and CAR T cells in multiple myeloma: a consensus report of the European Myeloma Network
Authors: Heinz Ludwig, Evangelos Terpos, Niels W.C.J. van de Donk, María‐Victoria Mateos, Philippe Moreau, Melitios-Athanasios Dimopoulos, Michel Delforge, Paula Rodríguez‐Otero, Jesús F. San Miguel, Kwee Yong, Francesca Gay, Hermann Einsele, Roberto Mina, Jo Caers, Christoph Driessen, Pellegrino Musto, Sonja Zweegman, Monika Engelhardt, Gordon Cook, Katja Weisel, Annemiek Broijl, Meral Beksaç, Jelena Bila, Fredrik Schjesvold, Michèle Cavo, Roman Hájek, Cyrille Touzeau, Mario Boccadoro, Pieter Sonneveld - The Lancet Oncology 2023 cited by 178
- LocoMMotion: a prospective, non-interventional, multinational study of real-life current standards of care in patients with relapsed and/or refractory multiple myeloma
Authors: María‐Victoria Mateos, Katja Weisel, Valerio De Stefano, Hartmut Goldschmidt, Michel Delforge, Mohamad Mohty, Michèle Cavo, Ravi Vij, Joanne Lindsey-Hill, Dominik Dytfeld, Emanuele Angelucci, Aurore Perrot, Reuben Benjamin, Niels W.C.J. van de Donk, Enrique M. Ocio, Christof Scheid, Francesca Gay, Wilfried Roeloffzen, Paula Rodríguez‐Otero, Annemiek Broijl, Anna Potamianou, Caline Sakabedoyan, Maria Semerjian, Sofia Keim, Vadim Strulev, Jordan M. Schecter, Martin Vogel, Robert Wapenaar, Tonia Nesheiwat, Jesús F. San Miguel, Pieter Sonneveld, Hermann Einsele, Philippe Moreau - Leukemia 2022 cited by 240
- Isatuximab, carfilzomib, and dexamethasone in relapsed multiple myeloma (IKEMA): a multicentre, open-label, randomised phase 3 trial
Authors: Philippe Moreau, Meletios Α. Dimopoulos, Joseph Mıkhael, Kwee Yong, Marcelo Capra, Thierry Façon, Roman Hájek, Ivan Špıčka, Ross Baker, Kihyun Kım, Gracia Martınez, Chang‐Ki Min, Luděk Pour, Xavier Leleu, Albert Oriol, Youngil Koh, Kenshi Suzuki, Marie‐Laure Risse, Gaëlle Asset, Sandrine Macé, Thomas G. Martin, Philippe Moreau, Meletios Α. Dimopoulos, Joseph Mıkhael, Kwee Yong, Marcelo Capra, Thierry Façon, Roman Hájek, Ivan Špıčka, Ross Baker, Kim Kihyun, Gracia Martınez, Min Chang‐Ki, Luděk Pour, Xavier Leleu, Albert Oriol, Koh Youngil, Kenshi Suzuki, Tom Martin, Hang Quach, Andrew Lim, Helen Crowther, Hanlon Sia, Cyrille Hulin, Mohamad Mohty, Gábor Mikala, Zsolt Nagy, Marta Reinoso Segura, Laura Rosiñol, Münci Yağcı, Mehmet Turgut, Mamta Garg, Gurdeep Parmar, Brad Augustson, Nelson Castro, Edvan de Queiroz Crusoé, Tomáš Pika, Sosana Delimpasi, Kenichi Ishizawa, Anup George, Т. С. Константинова, Javier de la Rubia, Kim Sung-Hyun, Ângelo Maiolino, Tony Reiman, Richard LeBlanc, Shigeki Ito, Junji Tanaka, А. С. Лучинин, I. V. Kryuchkova, Joaquín Martínez‐López, Jesse Shustik, Lionel Karlin, Anargyros Symeonidis, Miklós Egyed, Mario Petrini, Michèle Cavo, Michihiro Uchiyama, Hilary Blacklock, Mutlu Arat, James E. Griffin, Hannah Hunter, Tonda Buck, Αchilles Anagnostopoulos, Κωνσταντίνος Κωνσταντόπουλος, Tamás Masszi, Sara Bringhen, Barbara Gamberi, Yawara Kawano, Kim Jin Seok, Hakan Özdoğu, Fahir Özkalemkaş - The Lancet 2021 cited by 380
- Isatuximab plus pomalidomide and low-dose dexamethasone versus pomalidomide and low-dose dexamethasone in patients with relapsed and refractory multiple myeloma (ICARIA-MM): a randomised, multicentre, open-label, phase 3 study
Authors: Michel Attal, Paul G. Richardson, S. Vincent Rajkumar, Jesús F. San Miguel, Meral Beksaç, Ivan Špıčka, Xavier Leleu, Fredrik Schjesvold, Philippe Moreau, Meletios Α. Dimopoulos, Jeffrey Shang-Yi Huang, Jiří Minařík, Michèle Cavo, H. Miles Prince, Sandrine Macé, Kathryn P. Corzo, Frank Campana, Solenn Le-Guennec, Franck Dubin, Kenneth C. Anderson, Michel Attal, Paul G. Richardson, S. Vincent Rajkumar, Jesús F. San Miguel, Meral Beksaç, Ivan Špıčka, Xavier Leleu, Fredrik Schjesvold, Philippe Moreau, Meletios Α. Dimopoulos, Jeffrey Shang-Yi Huang, Jiří Minařík, Michèle Cavo, H. Miles Prince, Sandrine Macé, Kathryn P. Corzo, Frank Campana, Solenn Le-Guennec, Franck Dubin, Kenneth C. Anderson, Simon J. Harrison, Wojciech Janowski, Ian Kerridge, Andrew Spencer, Michel Delforge, Karel Fostier, Philip Vlummens, Ka Lung Wu, Richard LeBlanc, Michel Pavic, Michaël Sébag, Roman Hájek, Vladimír Maisnar, Luděk Pour, Henrik Gregersen, Lotfi Benbouker, Denis Caillot, Martine Escoffre‐Barbe, Thierry Façon, Laurent Frenzel, Cyrille Hulin, Lionel Karlin, Brigitte Kolb, Brigitte Pegourié, Aurore Perrot, Mourad Tiab, Laure Vincent, Dietger Niederwieser, Αchilles Anagnostopoulos, Sosana Delimpasi, Marie‐Christine Kyrtsonis, Anargyros Symeonidis, Árpád Illés, Gábor Mikala, Zsolt Nagy, Sara Bringen, Paolo Corradini, Fabio Ciceri, Roberto M. Lemoli, Anna Marina Liberati, Chiara Nozzoli, Renato Zambello, Shinsuke Iida, Takashi Ikeda, Satoshi Iyama, Morio Matsumoto, Chihiro Shimazaki, Kazutaka Sunami, Kenshi Suzuki, Michihiro Uchiyama, Youngil Koh, Kihyun Kım, Jae Hoon Lee, Chang‐Ki Min, Hillary Blacklock, Hugh J. B. Goodman, Annette Neylon, David Simpson, Sebastian Grosicki, Artur Jurczyszyn and 30 more - The Lancet 2019 cited by 636
- Daratumumab plus Bortezomib, Melphalan, and Prednisone for Untreated Myeloma
Authors: María‐Victoria Mateos, Meletios Α. Dimopoulos, Michèle Cavo, Kenshi Suzuki, Andrzej Jakubowiak, Stefan Knop, Chantal Doyen, Paulo Lúcio, Zsolt Nagy, Polina Kaplan, Luděk Pour, Mark Cook, Sebastian Grosicki, Andre H Crepaldi, Anna Marina Liberati, Philip Campbell, Tatiana Shelekhova, Sung‐Soo Yoon, Genadi Iosava, Tomoaki Fujisaki, Mamta Garg, Christopher Chiu, Jianping Wang, Robin Carson, Wendy Crist, William Deraedt, Huong Nguyen, Ming Qi, Jesús F. San Miguel - New England Journal of Medicine 2017 cited by 984
- Daratumumab plus pomalidomide and dexamethasone versus pomalidomide and dexamethasone alone in previously treated multiple myeloma (APOLLO): an open-label, randomised, phase 3 trial
Authors: Meletios Α. Dimopoulos, Evangelos Terpos, Mario Boccadoro, Sosana Delimpasi, Meral Beksaç, Eirini Katodritou, Philippe Moreau, Luca Baldini, Argiris Symeonidis, Jelena Bila, Albert Oriol, María‐Victoria Mateos, Hermann Einsele, Ioannis Orfanidis, Tahamtan Ahmadi, Jon Ukropec, Tobias Kampfenkel, Jordan M. Schecter, Yanping Qiu, Himal Amin, Jessica Vermeulen, Robin Carson, Pieter Sonneveld, Adrián Alegre Amor, Luca Baldini, Meral Beksaç, Angelo Belotti, Lotfi Benboubker, Britta Besemer, Sevgi Kalayoğlu Beşışık, Jelena Bila, Mario Boccadoro, Michèle Cavo, Javier de la Rubia Comos, Sosana Delimpasi, Meletios Α. Dimopoulos, Chantal Doyen, Dominik Dytfeld, Monika Engelhardt, Thierry Façon, Roberto Foà, Hartmut Goldschmidt, Sebastian Grosicki, Roman Hájek, Güner Hayri Özsan, Cyrille Hulin, Brian Iversen, Lionel Karlin, Eirini Katodritou, Stefan Knop, Marie‐Christine Kyrtsonis, Juan José Lahuerta, Xavier Leleu, Carmen Martínez Chamorro, María-Victoria Mateos Manteca, Nathalie Meuleman, Monique C. Minnema, Philippe Moreau, Massino Offidani, Albert Oriol Rocafiguera, Mustafa Pehlıvan, Luděk Pour, Henk Roerdink, Laura Rosinol Dacsh, Hans Salwender, Pieter Sonneveld, Anargyros Symeonidis, Charlotte Toftmann Hansen, Tülin Tuğlular, Ali Ünal, Philip Vlummens, Filiz Vural, Ka Lung Wu, Sonja Zweegman - The Lancet Oncology 2021 cited by 327
- International myeloma working group consensus recommendations on imaging in monoclonal plasma cell disorders
Authors: Jens Hillengaß, Saad Z. Usmani, S. Vincent Rajkumar, Brian G.M. Durie, María‐Victoria Mateos, Sagar Lonial, Cristina João, Kenneth C. Anderson, Ramón García‐Sánz, Eloísa Riva, Juan Du, Niels W.C.J. van de Donk, Jesús G. Berdeja, Evangelos Terpos, Elena Zamagni, Robert A. Kyle, Jesús F. San Miguel, Hartmut Goldschmidt, Sergio Giralt, Shaji Kumar, Noopur Raje, Heinz Ludwig, Enrique M. Ocio, Rik Schots, Hermann Einsele, Fredrik Schjesvold, Wen-Ming Chen, Niels Abildgaard, Brea Lipe, Dominik Dytfeld, Baldeep Wirk, Matthew T. Drake, Michèle Cavo, Juan José Lahuerta, Suzanne Lentzsch - The Lancet Oncology 2019 cited by 496
- Venetoclax or placebo in combination with bortezomib and dexamethasone in patients with relapsed or refractory multiple myeloma (BELLINI): a randomised, double-blind, multicentre, phase 3 trial
Authors: Shaji Kumar, Simon J. Harrison, Michèle Cavo, Javier de la Rubia, Rakesh Popat, Cristina Gasparetto, Vânia Hungria, Hans Salwender, Kenshi Suzuki, Inho Kim, Elizabeth A. Punnoose, Wan‐Jen Hong, Kevin J. Freise, Xiaoqing Yang, Anjla Sood, Muhammad Jalaluddin, Jeremy A. Ross, James E. Ward, Paulo Maciag, Philippe Moreau - The Lancet Oncology 2020 cited by 404
- Belantamab Mafodotin, Bortezomib, and Dexamethasone for Multiple Myeloma
Authors: Vânia Hungria, Paweł Robak, Marek Hus, Vera Zherebtsova, Christopher Wård, P. Joy Ho, Ana Carolina Ribas de Almeida, Roman Hájek, Kihyun Kım, Sebastian Grosicki, Hanlon Sia, Adam Bryant, Marcelo Pitombeira de Lacerda, Gracia Martınez, Anna Sureda Balarí, Irwindeep Sandhu, Claudio Cerchione, Peter Ganly, Meletios Α. Dimopoulos, Chengcheng Fu, Mamta Garg, Al‐Ola Abdallah, Albert Oriol, Moshe E. Gatt, Michèle Cavo, Robert M. Rifkin, Tomoaki Fujisaki, Michał Mielnik, Nick Pirooz, Astrid McKeown, Simon McNamara, Xiangdong Zhou, Maureen Nichols, Eric Lewis, Rachel Rogers, Hena Baig, Lydia Eccersley, Sumita Roy–Ghanta, Joanna Opalińska, María-Victoria Mateos - New England Journal of Medicine 2024 cited by 166
- Belantamab Mafodotin, Pomalidomide, and Dexamethasone in Multiple Myeloma
Authors: Meletios Α. Dimopoulos, Meral Beksac, Luděk Pour, Sosana Delimpasi, Vladimir Vorobyev, Hang Quach, Ivan Spicka, Jakub Radocha, Paweł Robak, Kihyun Kım, Michèle Cavo, Kazuhito Suzuki, Kristin Morris, Farrah Pompilus, Amy Phillips-Jones, Xiaoou L Zhou, Giulia Fulci, Neal Sule, Brandon E. Kremer, Joanna Opalińska, María‐Victoria Mateos, Suzanne Trudel - New England Journal of Medicine 2024 cited by 151
- Once-per-week selinexor, bortezomib, and dexamethasone versus twice-per-week bortezomib and dexamethasone in patients with multiple myeloma (BOSTON): a randomised, open-label, phase 3 trial
Authors: Sebastian Grosicki, Maryana Simonova, Ivan Špıčka, Luděk Pour, Iryrna Kriachok, Maria Gavriatopoulou, Halyna Pylypenko, Holger W. Auner, Xavier Leleu, Vadim Doronin, Ganna Usenko, Nizar J. Bahlis, Roman Hájek, Reuben Benjamin, Tuphan Kanti Dolai, Dinesh Kumar Sinha, Christopher P. Venner, Mamta Garg, Mercedes Gironella, Artur Jurczyszyn, Paweł Robak, Mónica Galli, Craig T. Wallington‐Beddoe, Atanas Radinoff, Galina Salogub, Don A. Stevens, Supratik Basu, Anna Marina Liberati, Hang Quach, Vesselina Goranova‐Marinova, Jelena Bila, Eirini Katodritou, Hanna Oliynyk, Sybiryna Korenkova, Jeevan Kumar, Sundar Jagannath, Philippe Moreau, Moshe Levy, Darrell White, Moshe E. Gatt, Thierry Façon, María‐Victoria Mateos, Michèle Cavo, Donna Reece, Larry D. Anderson, Jean-Richard Saint-Martin, Jacqueline Jeha, Anita Joshi, Yi Chai, Lingling Li, Vishnuvardhan Peddagali, Melina Arazy, Jatin J. Shah, Sharon Shacham, Michael Kauffman, Meletios Α. Dimopoulos, Paul G. Richardson, Sosana Delimpasi - The Lancet 2020 cited by 324
- Oral Ixazomib, Lenalidomide, and Dexamethasone for Multiple Myeloma
Authors: Philippe Moreau, Tamás Masszi, Norbert Grząśko, Nizar J. Bahlis, Markus Hansson, Luděk Pour, Irwindeep Sandhu, Peter Ganly, Bartrum W. Baker, Sharon Jackson, Anne-Marie Stoppa, David R. Simpson, Peter Gimsing, Antonio Palumbo, Laurent Garderet, Michèle Cavo, Shaji Kumar, Cyrille Touzeau, Francis K. Buadi, Jacob P. Laubach, Deborah Berg, Jianchang Lin, Alessandra Di Bacco, Ai-Min Hui, Helgi van de Velde, Paul G. Richardson - New England Journal of Medicine 2016 cited by 1,054
- Carfilzomib with cyclophosphamide and dexamethasone or lenalidomide and dexamethasone plus autologous transplantation or carfilzomib plus lenalidomide and dexamethasone, followed by maintenance with carfilzomib plus lenalidomide or lenalidomide alone for patients with newly diagnosed multiple myeloma (FORTE): a randomised, open-label, phase 2 trial
Authors: Francesca Gay, Pellegrino Musto, Delia Rota-Scalabrini, Luca Bertamini, Angelo Belotti, Monica Galli, Massimo Offidani, Elena Zamagni, Antonio Ledda, Mariella Grasso, Stelvio Ballanti, Antonio Spadano, Michele Cea, Francesca Patriarca, Mattia D'Agostino, Andrea Capra, Nicola Giuliani, Paolo de Fabritiis, Sara Aquino, Angelo Palmas, Barbara Gamberi, Renato Zambello, Maria Teresa Petrucci, Paolo Corradini, Michele Cavo, Mario Boccadoro - The Lancet Oncology 2021 cited by 244
- Overall survival with daratumumab, bortezomib, melphalan, and prednisone in newly diagnosed multiple myeloma (ALCYONE): a randomised, open-label, phase 3 trial
Authors: María‐Victoria Mateos, Michèle Cavo, Joan Bladé, Meletios Α. Dimopoulos, Kenshi Suzuki, Andrzej Jakubowiak, Stefan Knop, Chantal Doyen, Paulo Lúcio, Zsolt Nagy, Luděk Pour, Mark Cook, Sebastian Grosicki, Andre H Crepaldi, Anna Marina Liberati, Philip Campbell, Tatiana Shelekhova, Sung‐Soo Yoon, Genadi Iosava, Tomoaki Fujisaki, Mamta Garg, Maria Krevvata, Ying Chen, Jianping Wang, Anupa Kudva, Jon Ukropec, Susan Wróblewski, Ming Qi, Rachel Kobos, Jesús F. San Miguel - The Lancet 2019 cited by 438
- Pomalidomide, bortezomib, and dexamethasone for patients with relapsed or refractory multiple myeloma previously treated with lenalidomide (OPTIMISMM): a randomised, open-label, phase 3 trial
Authors: Paul G. Richardson, Albert Oriol, Meral Beksaç, Anna Marina Liberati, Mónica Galli, Fredrik Schjesvold, Jindriska Lindsay, Katja Weisel, Darrell White, Thierry Façon, Jesús F. San Miguel, Kazutaka Sunami, Peter O’Gorman, Pieter Sonneveld, Paweł Robak, С. В. Семочкин, Steve Schey, Xin Yu, Thomas Doerr, Amine Bensmaine, Tsvetan Biyukov, Teresa Peluso, Mohamed H. Zaki, Kenneth Anderson, Meletios Α. Dimopoulos, Niels Abildgaard, Howard L. Adler, Fevzi Altuntaş, Olga Meltem Akay, Bipinkumar Amin, Achilleas Anagnostopoulos, Larry D. Anderson, Pekka Anttila, Carla Araujo, Carlos Arce‐Lara, Yıldız Aydın, Supratik Basu, Ramakrishna Battini, Thaddeus Beeker, Lotfi Benboubker, Dina Ben‐Yehuda, Joan Bladé, Igor Wolfgang Blau, Ralph V. Boccia, Lillian Burke, Peter D. Byeff, Nicola Cascavilla, Michèle Cavo, Andrew Chantry, Yen Charles, Arvind Chaudhry, Alessandro Corso, Mark Coyne, Felipe de Arriba, Sosana Delimpasi, Pierre Desjardins, Binod Dhakal, Paolo Di Bartolomeo, Francesco Di Raimondo, Jan Dürig, Monika Engelhardt, Martine Escoffre‐Barbe, Graça Esteves, Max Flogegård, Nashat Gabrail, Barbara Gamberi, Mitchell Garrison, Julie Gay, Heinz Gisslinger, Hartmut Goldschmidt, Cristina Gonçalves, Laurent Gressot, Sebastian Grosicki, Wahid T. Hanna, Patrick Hayden, Maria Manuela Henriques Bernardo, Róbert Hermann, Viran Holden, Kirsti Honkalehto, Marianne Huben, John Huffman, Hannah Hunter, Marek Hus, Madan Jagasia, Sundar Jagganath, Murali Janakiram, Ishmael Jaiyesimi, Matthew Jenner, Cristina João, Peter Johnson, Artur Jurcyszyn, Sevgi Kalayoğlu Beşışık, Suman Kambhampati, Abraham S. Kanate, Ìhsan Karadoǧan, Ali Khojasteh, Dean Kirkel, Mieczysław Komarnicki, Maria‐Theresa Krauth, Phillip Kuriakose and 65 more - The Lancet Oncology 2019 cited by 385
